# Sedia Biosciences Corp — Form D

Sedia Biosciences Corp of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2013-05-21. The offering totals $285K, of which $285K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2013-05-21
- Form: D
- Accession: 0001577322-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $285K
- Amount sold: $285K
- Minimum investment: $10K
- Investors: 5
- Date of first sale: 2013-05-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-196794

## Issuer

- Name: Sedia Biosciences Corp
- CIK: 0001577322
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 4900 NE 122ND AVENUE, PORTLAND, OR, 97230
- Phone: 503-459-4159

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Roger I Gale | Director | Portland, OR |
| Ronald W Mink | Director | Portland, OR |
| Lynnor B Stevenson | Director | Portland, OR |
| Roger I Gale | Executive Officer | Portland, OR |
| Ronald W Mink | Executive Officer | Portland, OR |
| Roger I Gale | Promoter | Portland, OR |
| Ronald W Mink | Promoter | Portland, OR |

## More

- [CIK 1577322 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1577322&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001577322-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.